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ABST RACT
Epidermolysis bullosa (EB) is a rare, serious genetic disease, incurable
through the current means. Apart from this initial definition, there was
later some ease in the definition of the disease, including the
manifestations of toxic epidermal necrolysis and Stevens Johnson
syndrome in this entity. In medical practice, there are cases that do not
overlap with the description in the literature, thus the treatment must be
adapted and personalized to the particularities. We present the case of a
female new-born, with "de novo" mutation for the early-onset antenatal
epidermolysis and our personalized therapeutic management, based on
collagen from bovine corneas by enzymatic process. The histological
examination showed that the collagen membranes serve as a support for
the epithelial cells that formed a surface monolayer after 48 hours.
Therefore. this case report shows that collagen-based biomaterials could
be used to accelerate the dermal-epidermal healing in various conditions
of the child, such as Stevens Johnson syndrome, bullous epidermolysis
and widespread burns.

Introduction
Epidermolysis bullosa is a rare condition, with genetic
determinism, affecting less than 5 patients in 10,000 people
in Europe [1]. There is a polymorphism of the clinical
forms, the spectrum of manifestations varying from mild to
serious forms and the basic pathophysiological mechanism
consists in the exaggerated fragility of the intercellular
connections with the appearance of cleavage planes that
determine the occurrence of blisters on the skin and
mucous membranes in response to heat, local pressure, and
friction.
The term "epidermolysis bullosa" actually comprises a
heterogeneous group of over 25-30 vesicular hereditary
disorders that have been classified according to the level at
which the cleavage occurs and the blisters appear, as
follows [2]:
1. The epidermolytic form (cleavage of keratinocytes
with autosomal dominant, recessive or x-linked
transmission);
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2. The dermolytic (or dystrophic) form cleavage in
superficial dermal papillae and autosomal dominant or
recessive transmission;
3. The mixed form (Kindler syndrome).
Genetically, the mutations described are diverse:
• Autosomal dominant, recessive or x-linked intraepithelial forms with loci in regions 8q24, 12q13, 17q12q21, Xq 27-3qter;
• Junctional forms show autosomal recessive mutations
in the region 1q31, 1q32, 1q25-q31, 10q24-3, 17q11-qter,
18q 11.2;
• The dermolytic forms are due to dominant or recessive
mutations of the α1 polypeptide gene VII (COL7A) that
determine collagen synthesis and are located in the region
3p 21.3. There are “de novo” mutations due to genes of
unknown location.
According to the literature, the onset is immediately
after birth, which can affect the skin of the whole body, as
well as the mucous membranes, and trigger factors can be
minor, such as: hits, scratches, even more energetic
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touches. The repercussions are reducible, joint damage
occurs, periodontitis, edentation, nail damage, sclerosis,
severe protein and mineral deficiency [3].

Case presentation
We present the case of a "de novo" mutation for the
early-onset antenatal epidermolysis. The female child,
from a carefully monitored clinical and ultrasound
pregnancy, was born at the gestational age of 39 weeks.
There was nothing suggestive in the family health history,
both parents and the 2-year-old brother being absolutely
healthy. As additional information, the feeding of the
whole family, implicitly of the mother of the child during
the antepartum period, is made with foods from strictly
biological cultures, being very balanced in nutritional
principles. The mother did not show any pathology during
pregnancy. The only special mention was regarding the
stress perceived by the mother during pregnancy, in part
related to the COVID-19 pandemic. At the time around the
birth, all the regulations regarding the prevention of intrahospital dissemination of the Sars-Cov-2 infection were
respected according to the protocols, including social
distancing, facial mask wearing and frequent cleaning and
disinfection of the surfaces [4-6]. The mother was tested
negative for Sars-Cov-2 before admission. The postnatal
adaptation was good, W = 3,200 g, balanced cardiorespiratory, spontaneous motions, intestinal tract present.
In the first 12 hours postpartum, in the lumbar region,
buttock, and at the level of the upper limbs, blistering
lesions that break appeared, revealing large areas of dermis
(Figure 1).

After discharge, at the age of 42 days, W=3,240g, the
child receives home care recommendation for new and old
lesions. During the 8-month period, new lesions are
present, especially in the frictional areas. Two lesions
resulted in keloid scars and there were many recurrences in
the respective areas (region of the gluteal crease). At 9
months of age, the child has a severe degree of dystrophy
(W = 5,700g, without being associated with psychomotor
retardation) (Figures 2-4).

Figure 2. Early lesions in the gluteal region

Figure 3. Advanced lesions in the gluteal region

Figure 1. The blistering lesions
Due to the high septic risk, considering that in the first
24 hours about 50% of the area was affected, the decision
to transfer the child to NICU for supervision and care was
made. The hospitalization lasted for 40 days, during
which time local antiseptic solutions were applied, along
with hydration baths, emollients, local dressings,
treatment for hydro electrolytic disorder and broadspectrum
antibiotics
(meronem).
During
the
hospitalization period, the blistering lesions occurred at
the level of the entire skin, including at the level of the
buccal mucosa, except for the hairy area of the head.

Figure 4. Healing lesions
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Complementary examinations "targeted" on the
condition (bullous epidermolysis) were performed. At the
histological examination of the lesion, it was found that the
intercellular connections in the normal integumentary
architecture were altered by changes in collagen structures.
Karyotyping of the child and parents (performed at a
specialized institute in the UK) has not established genetic
mutations, the diagnosis made by experts being "transient
epidermolysis bullosa".
Blood tests revealed a significant degree of anemia
(Hb: 9.7g/dl with serum iron ~ 18 μg%), hypoalbuminemia
(2.9g/dl), hypocalcemia (7.9g/dl) and cultures from the
superinfected lesions from the gluteal crease determined
the presence of Pseudomonas aeruginosa.
A peculiarity of the case is that the child is still
breastfed, has no respiratory or digestive intercourse and
the complementary food has been extremely deficient
without high animal protein (meat, egg) and the diet is
deficient, of the lactovegetarian type.
The diagnosis of the child at 9 months is: epidermolysis
bullosa, secondary pyodermal infection (pseudomonas),
malnutrition II/III, iron deficiency, anemia, hypocalcemia.
The follow-up and dispensation of the case is lasting for
the chronic underlying disease (epidermolysis) and for the
associated conditions (malnutrition, anemia). The hygiene
rules are very strict, the disinfection and the continuous
dressing of the injuries being mandatory. Nutrition
recovery depends on the family's compliance, which
unfortunately is supportive of restrictive diets.
The literature establishes that, depending on the
severity of the disease, after the healing of the bullous
lesions, keloid scars may occur, some of them mutilating,
with limbs or segments in flexion, hair loss, nails, teeth,
(temporary) impaired vision depending on the location of
the typical lesions.
A unique feature of the case, in total discrepancy with
the data in the literature, is the "failure to agree" to the
early, antenatal onset of the severe postnatal evolution of
the lesions with the lack of genetic modifications and to
make the diagnosis of a "transient" form after karyotyping.
This case highlights the importance of the signed informed
consent, after presenting all possible incidents and
complications, as well as the therapeutic alternatives, this
being an important element in building a strong and
confident patient-doctor relationship, increase adherence
to treatment and prevent the possible medical errors [7,8].
Therapeutic options and decisions in our case
Type I collagen was prepared from bovine corneas by
enzymatic processes, using pepsin (Merck) in acetic acid
medium. For the solution obtained, the collagen content
was determined by hydroxyproline (Hyp) dosage,
according to the modified Woesneer method and the
content in hexozoamines (by the Elson Morgan method).
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GAG (KS-keratan sulfate mixture) and CS (chondroitin
sulfate) were extracted from the same corneal tissue by
papain enzymatic method and purified by ion exchange
chromatography and ethanol precipitation. The
composition of the GAG mixture was determined by
measuring uronic acids (for CS) and neutral carbohydrates
(for KS).
Membrane preparation: Type I collagen solution was
diluted with 0.5M acetic acid to a final concentration of
0.4 % (g/g) and dialyzed relative to distilled water to its
pH.
The GAG mixture, containing two parts KS and one CS
was dissolved in distilled water at a concentration of 0.85
and added to the collagen solution, through continuous
stirring.
Variants of COL-GAG (collagen-glycosaminoglycan)
solutions in ratio 1: 1, 2: 1, 4: 1, 7: 7 and 10: 1 were
prepared. The COL type I solution and COL-GAG
composition were dried as a membrane by evaporation of
the solvent at 35°C for 48 hours.
COL-GAG sponges were prepared identically to the
membranes, with the exception that the dilution was made
at a concentration of 0.8% (g/g). The drying of the COLGAG composition was carried out by lyophilization, for 72
hours, obtaining elastic white foam foils.
The sponges based on fibrillary collagen and gelatin
(COL F-Gel) were obtained according to the following
procedure (Figure 5):

Figure 5. The procedure used to obtain sponges based
on fibrillar collagen and gelatin
A stabilized line of calf kidney epithelial cells was
introduced into Petri culture vessels in contact with
collagen membranes and sponges at 37°C for 96 hours. The
histological examination showed that the collagen
membranes serve as a support for the epithelial cells that
formed a surface monolayer after 48 hours after
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cultivation. At 96 hours of culture, the cells had a normal
appearance (Figures 6, 7).

Figure 9. Epithelial cells grown 96 hours on the
COL F-Gel sponge
Figure 6. Optical microscopy images of epithelial
cells grown on collagen membranes, 40 hours

Figure 7. Optical microscopy images of epithelial
cells grown on collagen membranes, 96 hours
Regarding the collagen sponges at 48 hours, cells were
observed only on their surface, and at 96 hours, cells
penetrated into the three-dimensional network structure
and attached to the alveolar structure (much better in COLGAG structures compared to COL) (Figures 8, 9).

Figure 8. Epithelial cells grown on sponge by COLGAG. After 96 hours, the cells migrated inside the
sponge and attached to its alveolar structure

Discussions
From the point of view of the clinical manifestations,
certain types of dystrophic epidermolysis (EB) have been
described, along with the most frequent type of multiple
forms of epidermolysis [9].
1. Hallopeau-Siemens autosomal recessive EB - the
most severe form, with congenital blisters on a large
percentage of the body surface and sometimes with
portions absent from the integument (caused by traumas
during birth). The blisters also affect the mucous
membranes, subsequently causing integumentary scarring
in the digestive tract (esophagus, buccal cavity) as well,
thus leading to significant complications: post-keloid scar
contraction, fusion of fingers, nail disappearance, eye
inflammation, chronic malnutrition. On the long term,
there is an increased risk of squamous, lethal carcinoma.
2. Autosomal recessive non-Hallopeau-Siemens EB the blisters are usually more limited on the hands and feet
(elbows, knees), post-bulging scars occur, not very
mutilating, as well as nail malformative changes.
3. Autosomal dominant EB is the mildest form of EB,
the blisters are usually confined to the hands, feet, knees,
elbows.
In less severe situations, abnormal nail growth is the
only sign of the disease. In recent years, epigenetic causes
have been most frequently discussed, as being incriminated
in the action of the gene switch, which activates certain
genes or suppresses the action of others, thus transforming
them into dormant genes.
The generic known period of 1,000 days is defining in
the development of a child. It practically starts at the time
of conception and ends after 2 years of life. Excluding a
multitude of triggering factors (diet, medicines, nuisances,
etc.) special attention is paid to maternal stress during the
antepartum period [10,11].
There has been a study for a period of 13 years (see
book "1,000 days"), which shows an increase of cortisol (as
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a stress hormone) during the antepartum period, during
pregnancy, postpartum, associated with the increase of
cortisol in the newborn and remote effects, including a
change in neuroplasticity. Affected children showed an
increase in the stress level and a decrease in adaptation to
the beginning of the new school year or to public speaking
[12,13].
In addition, stressors (e.g., noise, light) applied to
batches of laboratory mice caused atopic dermatitis lesions,
with changes in the rate of cell regeneration and in normal
cellular architecture. Collagen, as a biomaterial component
and support, has been recently used in medicine more and
more often. Its properties have been exploited, such as the
behavior of biological dressing and the non-stick and antiadherence qualities [14-17].
In recent years, nutrition has been underlined as an
important trigger of bullous skin diseases [18]. The wound
management has been under debate in order to reach a
consensus [19]. The physiological disappearance of the
provisional matrix of a clot is as important as its formation.
The inadequate removal of fibrin may interfere with the
normal process of wound healing [20,21].
This study shows that biomaterials based on COL and
GAG may be a possible future solution, at least in patients
with extensive epithelial disorders (epidermolysis, StevenJohnson syndrome, severe burns, corneal lesions and so on)
[22,23].

Highlights
✓ Epidermolysis bullosa is a rare condition with genetic
determinism, with a significant polymorphism of the
clinical forms.
✓ The follow-up should carefully monitor the cutaneous
mucosal relapses, the growth and development of the
child and the possible sequelae.
✓ Shortening the healing time with collagen membranes
will reduce the risk of further septic complications,
dehydration and hydro-electrolytic imbalance.

Conclusions
In conclusion, the presented case has the following
features: early onset (antenatal), lack of possible triggering
factors in the mother (except for stressful periods), lack of
changes in the genetic karyotype, severity of the skin
condition,
association
of
deficient
conditions
(malnutrition, anemia, rickets).
Although diagnosed with the "mild" form from a
genetic point of view, the evolution is autosomal recessive
Hallopeau-Siemens type EB. The evolution will have to be
carefully monitored in terms of cutaneous mucosal
relapses, the growth and development of the child and of
the possible sequelae.
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Collagen-based biomaterials can be used to accelerate
dermal-epidermal healing in various conditions of the child
(Stevens Johnson syndrome, bullous epidermolysis,
widespread burns). Shortening the healing time with
collagen membranes will reduce the risk of further
complications: septic - infections, hydro electrolytic dehydration.
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